A common polymorphism - a variation in a person's DNA sequence that is found with regularity in the general population - can lead to a chain of events that dictates how a tumor will progress in...
Bloodstream infections correlate with distance from the equator and health care spending
1/01/2015
Twenty-three health centers on six continents participated in study of bloodstream infectionsWhere you live affects the type of bacteria that cause bloodstream infections, according to...
Autism, cancer mutations found in unexplored regions of the genome
12/31/2014
Scientists and engineers have built a computer model that has uncovered disease-causing mutations in large regions of the genome that previously could not be explored.
Changing diet to unmask cancer vulnerabilities and reduce cancer risk
12/31/2014
Many recent studies showed that calorie restrictions reduce the incidence of cancer, whereas high-calorie diets cause obesity and diabetes, both of which increase the risk of developing cancers.
Levels of cancer-causing chemicals in smokeless tobacco products influence carcinogen exposure
12/31/2014
Higher levels of cancer-causing chemicals called tobacco-specific nitrosamines in smokeless tobacco products led to greater exposure to these carcinogens even after taking into account how much or...
The U.S. Food and Drug Administration is a science-based regulatory agency that works to protect and promote the public health.
Virotherapy with immunotherapy shows promise against pancreatic cancer
12/30/2014
A study shows how combining virotherapy and immunotherapy - using a cancer-killing virus armed with a gene that dampens immune response - shows promise against pancreatic cancer.
New review of prostate cancer research published
12/30/2014
The American Journal of Hematology/Oncology, has published a provocative article exploring the role of follicle-stimulating hormone (FSH) in the development, progression and potential treatment of...
FDA approves Opdivo for advanced melanoma
12/30/2014
The U.S. Food and Drug Administration has granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced)...
Armed virus shows promise as treatment for pancreatic cancer
12/30/2014
A new combination of two different approaches - virotherapy and immunotherapy - is showing "great promise" as a treatment for pancreatic cancer, according to new research from Queen Mary University...